Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/tid.13426 http://scihub22266oqcxt.onion/10.1111/tid.13426 32702150!7404372!32702150     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Transpl+Infect+Dis 2020 ; 22 (6): e13426 Nephropedia Template TP {{tp|p=32702150|t=2020. Kidney transplant recipients infected by COVID-19: Review of the initial published experience |pdf=|usr=}}{{32702150}} gab.com Text Kidney transplant recipients infected by COVID-19: Review of the initial published experience JO: Transpl Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32702150 #FOAvip There is an accumulating body of literature surrounding the impact of COVID-19 infection in solid organ transplant recipients. The aim of this review was to summarize the existing literature specifically in kidney transplant (KTx) recipients, with an emphasis on the epidemiology, clinical presentation, laboratory findings, post-operative outcomes, and therapeutic strategies currently employed. We identified thirty-seven studies published between January 1, 2020, and June 10, 2020, that were included in our analysis. As is reported in the general population, there is a wide variation in COVID-19 presentation among KTx patients, ranging from asymptomatic to life-threatening end-organ failure. The most common symptoms are predominantly respiratory and associated with fever. On laboratory evaluation, many patients present with lymphopenia and increased CRP, which are both associated with inferior outcomes. The majority of patients with severe symptoms have been managed with reduction of immunosuppression, including decreased doses of CNIs and withdrawal of MMF. Lastly, although there are no high-level data supporting the use of immunomodulatory drugs, such as IL-6 inhibitors, early experiences have suggested these drugs may improve outcomes in KTx patients with severe COVID-19. Twit Text FOAVip Kidney transplant recipients infected by COVID-19: Review of the initial published experience ????Transpl Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32702150 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32702150 #FOAvip English Wikipedia <ref>{{Cite pmid|32702150}}</ref> Kidney transplant recipients infected by COVID-19: Review of the initial published experience #MMPMID32702150 Moris D; Kesseli SJ; Barbas AS Transpl Infect Dis 2020[Dec]; 22 (6): e13426 PMID32702150show ga There is an accumulating body of literature surrounding the impact of COVID-19 infection in solid organ transplant recipients. The aim of this review was to summarize the existing literature specifically in kidney transplant (KTx) recipients, with an emphasis on the epidemiology, clinical presentation, laboratory findings, post-operative outcomes, and therapeutic strategies currently employed. We identified thirty-seven studies published between January 1, 2020, and June 10, 2020, that were included in our analysis. As is reported in the general population, there is a wide variation in COVID-19 presentation among KTx patients, ranging from asymptomatic to life-threatening end-organ failure. The most common symptoms are predominantly respiratory and associated with fever. On laboratory evaluation, many patients present with lymphopenia and increased CRP, which are both associated with inferior outcomes. The majority of patients with severe symptoms have been managed with reduction of immunosuppression, including decreased doses of CNIs and withdrawal of MMF. Lastly, although there are no high-level data supporting the use of immunomodulatory drugs, such as IL-6 inhibitors, early experiences have suggested these drugs may improve outcomes in KTx patients with severe COVID-19. |*Kidney Transplantation[MESH] |Adult[MESH] |COVID-19/complications/*diagnosis/epidemiology/mortality[MESH] |Female[MESH] |Humans[MESH] |Immunocompromised Host/drug effects[MESH] |Immunosuppression Therapy/methods[MESH] |Interleukin-6/antagonists & inhibitors[MESH] |Male[MESH] |Middle Aged[MESH]Kidney transplant recipients infected by COVID-19: Review of the initi(epmc).pdf DeepDyve Pubget Overpricing